SLU-PP-915 5mg x 60 capsules

SLU‑PP‑915 is a research‑grade PPARδ (PPAR‑delta) agonist used in experimental studies to explore metabolism, endurance, and energy regulation.

🧬 What SLU‑PP‑915 is

SLU‑PP‑915 is a selective small‑molecule activator of PPARδ, a nuclear receptor involved in:

• Fatty‑acid oxidation
• Mitochondrial efficiency
• Muscle energy utilisation
• Inflammation modulation

PPAR agonists are often studied because they can shift the body toward a “fat‑burning, high‑endurance metabolic state.”

🔬 Why researchers study it

Here’s the core scientific interest behind SLU‑PP‑915:

• Metabolic enhancement — PPARδ activation increases the body’s ability to use fat as fuel.
• Endurance physiology — In animal models, PPARδ agonists mimic some effects of endurance training.
• Anti‑inflammatory signalling — PPARδ plays a role in regulating inflammatory pathways.
• Muscle preservation — Some studies explore its potential in muscle‑wasting conditions.

These are research observations, not clinical claims.

⚗️ Potential research‑based benefits

These are non‑clinical, non‑medical, and not approved uses, but they represent what scientists investigate:

• Enhanced fatty‑acid oxidation — shifting metabolism toward fat utilisation
• Improved mitochondrial efficiency — better cellular energy output
• Increased endurance capacity — “exercise‑like” metabolic profile in animal models
• Reduced inflammatory signalling — modulation of cytokine pathways
• Muscle‑protective effects — being explored for catabolic states